|
CN112220916A
|
|
Preparation process of biological enzyme tablet and product thereof
|
|
CN108309949A
|
|
A kind of preparation method and products thereof of morphine osmotic pump tablet
|
|
CN105456223A
|
|
Mesalazine sustained-release pellets, preparation method thereof and mesalazine sustained-release capsule
|
|
CN105476973A
|
|
Felodipine sustained release tablet and preparation method thereof
|
|
CN105326806A
|
|
Felodipine sustained release tablet and preparation method thereof
|
|
CN105343033A
|
|
Ibuprofen sustained-release pellet and preparation method thereof
|
|
CN105412040A
|
|
Nifedipine controlled release tablet and preparation method thereof
|
|
CN105380915A
|
|
Amlodipine besylate composition, preparation method thereof, and amlodipine besylate tablet
|
|
CN105395508A
|
|
Ibuprofen-codeine phosphate compounding preparation and preparation method therefor
|
|
CN105153222A
|
|
Purification method of creatine phosphate sodium
|
|
CN105203697A
|
|
Method for measuring content of EDTA-2Na (ethylene diamine tetraacetic acid-2Na) in esomeprazole sodium for injection
|
|
CN105132489A
|
|
Preparation method for creatine phosphate sodium
|
|
CN104971073A
|
|
Famotidine calcium carbonate and magnesium hydroxide chewable tablet preparation method and product thereof
|
|
CN104906057A
|
|
Preparation method for famotidine calcium and magnesium pellet type chewable tablets and products
|
|
CN105315444A
|
|
Purification method of polyethylene glycol monomethyl ether-polylactic acid amphiphilic segmented copolymer for injection
|
|
CN105287402A
|
|
Docetaxel polymer micelle freeze-dried preparation and special solvent composition
|
|
CN103142521A
|
|
Glibenclamide tablet and preparation method thereof
|
|
CN102813636A
|
|
Nateglinide tablet and its preparation method
|
|
CN102727432A
|
|
Stable moxifloxacin hydrochloride glucose injection
|
|
CN102911928A
|
|
Immobilized method of creatine kinase
|
